Zdrowie i gospodarka · 01/09/2011

FDA Releases Guidance on PET Drug Applications for New Drug Submissions

The Food and Drug Administration (FDA) has made available a new guidance document to help manufacturers of positron emission tomography (PET) drugs prepare and submit new drug applications (NDAs) or abbreviated new drug applications (ANDAs) in compliance with federal regulations.